Finkurve Financial Services Limited announced on November 14, 2025, that there was no deviation in the use of proceeds from its recent ₹141.50 crore preferential issue of equity shares and share warrants. This declaration was made in compliance with Regulation 32(1) of the Securities and Exchange Board of India (SEBI) Listing Obligations and Disclosure Requirements Regulations, 2015. The funds raised during the quarter ending September 30, 2025, were confirmed to be utilized for the stated purposes in the offer document without any significant variances.

The company conducted the fundraising on May 21 and May 27, 2025, with the proceeds allocated primarily for onward lending, investment, and repayment of borrowings incurred in the normal course of business. As of the report period, ₹111.50 crore had been utilized, which corresponds to 75% of the share warrants subscription amount that remains to be received. The Audit Committee reviewed the statement and confirmed the adherence to the original financial objectives, ensuring transparency and accountability in the fund utilization process.

Finkurve's compliance report, which was submitted to the BSE and NSE, reflects the company's commitment to maintaining strict oversight of its financial practices. The monitoring agency for this transaction is CRISIL Rating Limited, which is tasked with ensuring that the raised funds are used as intended. The company’s proactive approach in reporting and adherence to regulatory requirements underscores its dedication to investor confidence and operational integrity.